share_log
Breakings ·  Dec 10, 2024 21:00
Astria Therapeutics Announces FDA Clearance of Ind Application for Star-0310, a Monoclonal Antibody Ox40 Antagonist for the Treatment of Atopic Dermatitis
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment